Prognostic utility of gamma-glutamyl transpeptidase to platelet ratio in patients with solitary hepatitis B virus-related hepatocellular carcinoma after hepatectomy

Figure 4 Subgroup analyses for gamma-glutamyl transpeptidase-to-platelet ratio level and combined analyses of gamma-glutamyl transpeptidase-to-platelet ratio levels and variables in overall survival and recurrence-free survival of solitary hepatitis B virus-related hepatocellular carcinoma. A: Subgroup analyses for overall survival (OS) and recurrence-free survival (RFS); B: Combined analyses with tumor size, cirrhosis, alpha-fetoprotein (AFP), and microvascular imaging (MVI) for OS; C: Combined analyses with tumor size, cirrhosis, AFP, and MVI for RFS. GPR: Gamma-glutamyl transpeptidase-to-platelet ratio; HR: Hazard ratio; OS: Overall survival; BMI: Body mass index; HR: Hazard ratio; AFP: Alpha-fetoprotein; HBV: Hepatitis B virus; BCLC: Barcelona Clinic Liver Cancer; F: Female; M: Male.